Exane Derivatives Alcon Inc Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Alcon Inc stock. As of the latest transaction made, Exane Derivatives holds 4,429 shares of ALC stock, worth $406,537. This represents 0.2% of its overall portfolio holdings.
Number of Shares
4,429
Previous 2,848
55.51%
Holding current value
$406,537
Previous $225,000
37.33%
% of portfolio
0.2%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding ALC
# of Institutions
717Shares Held
254MCall Options Held
2.51MPut Options Held
2.06M-
Vanguard Group Inc Valley Forge, PA19.1MShares$1.75 Billion0.03% of portfolio
-
Credit Suisse Ag Zurich, V815.5MShares$1.42 Billion1.27% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL14.2MShares$1.3 Billion0.37% of portfolio
-
Norges Bank Oslo, Q812.3MShares$1.13 Billion0.17% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA12MShares$1.1 Billion2.19% of portfolio
About ALCON INC
- Ticker ALC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 490,087,008
- Market Cap $45B
- Description
- Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...